InvestSMART

Nexalis Therapeutics Ltd (ASX:NX1)

ALERT: Price-sensitive ASX Announcement for NX1
Current share price for NX1 : $0.010 -0.015 (-60%)+
Announcement
Release
22 May 2026 9:38AM
Price at Release
$0.025
Full Release
download
Summary
On 22 May 2026, Nexalis Therapeutics Ltd (ASX: NX1) announced a trading halt on its securities at the request of the company. The halt is pending an announcement concerning its existing debt funding facility and will remain until the earlier of the announcement or the commencement of normal trading on 26 May 2026. The request, in compliance with ASX Listing Rule 17.1, aims to assist the company in managing its continuous disclosure obligations. The board of Nexalis Therapeutics Ltd has approved the trading halt request.
Key Points
  • Nexalis Therapeutics Ltd requested a trading halt for its securities.
  • The trading halt is pending an announcement regarding its existing debt funding facility.
  • The trading halt will remain until the release of the announcement or the commencement of normal trading on 26 May 2026.
  • The request for a trading halt is in accordance with ASX Listing Rule 17.1.
  • The company's board approved the request for a trading halt.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.